FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors

SYNGENE

629.9
+16.4 (2.67%)
Updated 03:28 28/07 IST

SYNGENE Buy or Sell - FrontPage Forums

2 Users have submitted 2 trade ideas of Rs. 112,624.5 for SYNGENE
Disclaimer
100% Bullish
0% Bearish

SYNGENE Buy or Sell - Brokerage Reports

No. of reports in last year
1
No. of analysts
1
Average Consensus Forecast
635
Consensus Potential
3.39%
See SYNGENE Share Price Targets >>

SYNGENE Ratings

Long term SYNGENE rating by FrontPage users
5/5 (1 Ratings)
Find answers to all your questions on live SYNGENE message board: Is SYNGENE buy or sell? Should I buy SYNGENE shares? Why are SYNGENE shares falling? Should I invest in SYNGENE stock?

  1. Home
  2. SYNGENE Forum

SYNGENE Share Price Discussion

Like
Reply
N
Reputation: 15,707 • Yesterday 3:36 AM
Margin performance in line with expectations: Jonathan Hunt, Syngene
"Given the second wave of the pandemic that we had in India, we have seen pretty strong sales on Remdesivir: the product that we manufacture under licence from Gilead. That, of course, gave an additional boost in the quarter."
The Economic Times
Like
Reply
W
Reputation: 71 • Jul 24 6:21 AM
1
Reply
N
Reputation: 15,707 • Jul 23 4:46 AM
Sell Syngene International, target price Rs 515: Yes Securities
Syngene International Ltd., incorporated in the year 1993, is a Mid Cap company (having a market cap of Rs 25160.00 Crore) operating in Pharmaceuticals sector.
The Economic Times
Like
Reply
Like
Reply

Strong earnings 💪
1⃣ #HAVELLS : margins at 13.6% vs 8.9%
2⃣ #JUBLFOOD : Revenue up 130% at Rs 893 cr, management says worst is behind
3⃣ #GLAND : Rev Up 31% to 1154cr
4⃣ #SYNGENE : Rev Up 41% to 595cr
5⃣ #ISEC : Highest ever quarterly addition of 3.9 lakh clients
2
Reply

#SYNGENE executed a 5-year agreement with #IAVI for HIV drug

#BHARTIARTL and #Intel announce collaboration to accelerate 5G in India

#NuvocoVistas Corporation gets #SEBI approval to float Rs. 5000 crore IPO
1
Reply
N
Reputation: 15,707 • Jul 21 6:06 AM
Syngene International Q1 results: Net profit rises 33% to Rs 77 cr; John Shaw to step down from board
Consolidated revenue from operations of the company stood at Rs 594.5 crore for the quarter under consideration. It was Rs 421.6 crore for the same period a year ago.
The Economic Times
1
Reply
1
Reply

#SYNGENE Q1 : Net Profit Down 52 % To Rs 77.3 cr (QOQ), up 33 % YOY
Revenue Down 10 % To Rs 594 cr (QOQ), Up 41 % YOY
Like
Reply
S
Reputation: 3,069 • Jul 19 2:08 AM
Like
Reply
S
Reputation: 0 • Jul 19 6:21 AM

Type
Buy
Instrument
SYNGENE
Entry Price
₹662.85
Price@Trade
₹663.5
Target Price
₹675
Stop Price
₹655
Valid Till
Jul 20, 2021 3:20 AM
Margin
₹33,142.5 approx for 50 Qty
Status
Target Achieved
Exit Price
₹675
Net P&L
+₹607.5 (+1.83%)
Like
Reply (2)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
Jul 19 6:22 AM

Update
Trade Entered
Entry Price
₹662.85
TrackerBot @trackerbot
Jul 19 8:53 AM

Update
Target Achieved
Exit Price
₹675

Type
Buy
Instrument
SYNGENE
Entry Price
₹665
Price@Trade
₹669.95
Target Price
₹700
Stop Price
₹650
Valid Till
Jul 19, 2021 3:20 AM
Margin
₹23,275 approx for 35 Qty
Status
Exited
Exit Price
₹658.45
Net P&L
-₹229.25 (-0.98%)
Like
Reply (2)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
Jul 16 8:50 AM

Update
Trade Entered
Entry Price
₹665
Yash Gosiya @yashgosiya
Jul 19 2:46 AM

Update
Exited
Exit Price
₹658.45
Net P&L
-₹229.25 (-0.98%)

Type
Buy
Instrument
SYNGENE
Entry Price
₹683.75
Price@Trade
₹683.75
Target Price
₹750
Stop Price
₹650
Valid Till
Aug 16, 2021 3:20 AM  Jan 17, 2023 3:20 AM
Margin
₹6,837.5 approx for 10 Qty
Status
Stoploss Hit
Exit Price
₹650
Net P&L
-₹337.5 (-4.94%)
Like
Reply (2)
swap_vert
Trade
See all replies
DEEP @deepparakhiya26
Jul 16 7:24 AM

Update
Time Extended
Price @ Update
₹651.75
Original Time
Aug 16, 2021 3:20 AM
New Time
Jan 17, 2023 3:20 AM
TrackerBot @trackerbot
Jul 16 7:27 AM

Update
Stoploss Hit
Exit Price
₹650

Type
Buy
Instrument
SYNGENE
Entry Price
₹672.95
Price@Trade
₹672.95
Target Price
₹697.1
Stop Price
₹650
Valid Till
Jul 16, 2021 3:20 AM
Margin
₹67,295 approx for 100 Qty
Status
Exited
Exit Price
₹681.75
Net P&L
+₹880 (+1.31%)
Like
Reply (1)
swap_vert
Trade
See all replies
ANAND @anand-rJZT7SY6O
Jul 16 3:07 AM

Update
Exited
Exit Price
₹681.75
Net P&L
+₹880 (+1.31%)
Like
Reply
Like
Reply
S
Reputation: 3,324 • Jul 15 5:25 AM
Shivansh in SYNGENE
#SYNGENE Volumes were dry But should not go bel...
2
Reply
Like
Reply
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 2,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
  • SYNGENE - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization11,776
    Enterprise Value11,596.5
    Price to Earnings38.61
    Price to Book Value6.82
    Return on Capital Employed0.16
    Return on Equity0.18
    Face Value10
    Dividend YieldNA
  • SYNGENE - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    23-Oct-20ICICIdirect.comBuy635
    14-May-20ICICIdirect.comBuy390
    24-Jan-20ICICIdirect.comHold360
    26-Jul-19ICICIdirect.comBuy360
    25-Apr-19ICICIdirect.comBuy178.75
    SYNGENE Brokerage Price Target
  • SYNGENE Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Jul 28614.8637.95614.5628.45
    Jul 27629.8634.95610.05613.5
    Jul 26625637.9618.15628.85
    Jul 23624.9638614.45628.15
    Jul 22659.8665619.6627.7
  • SYNGENE Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹607.76
    30 Day Moving Average₹598.97
    50 Day Moving Average₹593.57
    100 Day Moving Average₹576.62
    200 Day Moving Average₹577.97
  • SYNGENE - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue1,4231,200.90.18
    Operating Profit391407.6-0.04
    Profit Before Tax372346.50.07
    Net Income305287.30.06
  • SYNGENE - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Shareholder's Funds1,7271,413.10.22
    Total Liabilities1,5071,394.20.08
    Total Assets3,2342,807.30.15
  • SYNGENE - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity445397.70.12
    Cash from Investing Activity-349-469.7-0.26
    Cash from Financing Activity-78-80.8-0.03
    Net Cash Flow17-152.8-1.11
  • SYNGENE - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.090.1
    Return on Equity0.180.2
    Return on Capital Employed0.160.16
  • SYNGENE - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.65
    3 Year CAGR Growth in Operating Profit0.39
    3 Year CAGR Growth in EBIDTA0.79
    3 Year CAGR Growth in Net Income0.74
    3 Yr CAGR Growth - Diluted EPS0.73
  • SYNGENE - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue1.59
    5 Year CAGR Growth in Operating Profit1.32
    5 Year CAGR Growth in EBIDTA2.04
    5 Year CAGR Growth in Net Income1.99
    3 Yr CAGR Growth - Diluted EPS-0.61
  • SYNGENE - Recent News

    keyboard_arrow_down
    NewsBot
    Yesterday 3:36 AM
    Margin performance in line with expectations: Jonathan Hunt, Syngene
    The Economic Times
    NewsBot
    Jul 23 4:46 AM
    Sell Syngene International, target price Rs 515: Yes Securities
    The Economic Times
    NewsBot
    Jul 21 6:06 AM
    Syngene International Q1 results: Net profit rises 33% to Rs 77 cr; John Shaw to step down from board
    The Economic Times
    NewsBot
    Apr 30 6:21 AM
    Sell Syngene International, target price Rs 400: Yes Securities
    The Economic Times
    NewsBot
    Apr 29 2:46 AM
    Discovery, development, dedicated centres and manufacturing biz contribute to Syngene growth: Jonathan Hunt
    The Economic Times
    NewsBot
    Mar 9 2:23 AM
    Neutral UPL; Target Of Rs 631: Motilal Oswal
    Moneycontrol
    NewsBot
    Feb 8 9:58 AM
    Buy UPL; Target Of Rs 632: Sharekhan
    Moneycontrol
    NewsBot
    Feb 5 8:58 AM
    Accumulate UPL; Target Of Rs 601: Prabhudas Lilladher
    Moneycontrol
    NewsBot
    Feb 4 10:53 AM
    Accumulate UPL; Target Of Rs 609: Dolat Capital Market
    Moneycontrol
    NewsBot
    Feb 4 10:53 AM
    Neutral UPL; Target Of Rs 574: Motilal Oswal
    Moneycontrol
  • SYNGENE - Related Communities

    keyboard_arrow_down
    Larsen & Toubro Ltd. NSE: LT | BSE: 5...
    Adani Ports and Special Economic Zone...
    Indian Railway Catering And Tourism C...
    Voltas Ltd. NSE: VOLTAS | BSE: 500575...
    Info Edge (India) Ltd. NSE: NAUKRI | ...
    Century Textiles & Industries Ltd. NS...
    Delta Corp Ltd. NSE: DELTACORP | BSE:...
    Infibeam Avenues Ltd. NSE: INFIBEAM |...
    Affle (India) Ltd. NSE: AFFLE | BSE: ...
    Indiamart Intermesh Ltd. NSE: INDIAMA...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.

PrivacyTerms
FrontPage © 2020